- Home
- CMS vs BNTX Comparison
CMS vs BNTX Comparison
Compare CMS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMS
- BNTX
- Stock Information
- Founded
- CMS 1987
- BNTX 2008
- Country
- CMS United States
- BNTX Germany
- Employees
- CMS N/A
- BNTX N/A
- Industry
- CMS Power Generation
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMS Utilities
- BNTX Health Care
- Exchange
- CMS Nasdaq
- BNTX Nasdaq
- Market Cap
- CMS 20.5B
- BNTX 23.9B
- IPO Year
- CMS N/A
- BNTX 2019
- Fundamental
- Price
- CMS $66.82
- BNTX $114.13
- Analyst Decision
- CMS Buy
- BNTX Strong Buy
- Analyst Count
- CMS 15
- BNTX 15
- Target Price
- CMS $69.21
- BNTX $143.50
- AVG Volume (30 Days)
- CMS 2.4M
- BNTX 658.5K
- Earning Date
- CMS 01-30-2025
- BNTX 11-04-2024
- Dividend Yield
- CMS 3.08%
- BNTX N/A
- EPS Growth
- CMS 37.73
- BNTX N/A
- EPS
- CMS 3.50
- BNTX N/A
- Revenue
- CMS $7,476,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- CMS $6.39
- BNTX N/A
- Revenue Next Year
- CMS $3.36
- BNTX N/A
- P/E Ratio
- CMS $19.10
- BNTX N/A
- Revenue Growth
- CMS N/A
- BNTX N/A
- 52 Week Low
- CMS $55.10
- BNTX $76.53
- 52 Week High
- CMS $72.40
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- CMS 43.71
- BNTX 49.15
- Support Level
- CMS $65.47
- BNTX $109.52
- Resistance Level
- CMS $66.82
- BNTX $115.34
- Average True Range (ATR)
- CMS 1.07
- BNTX 4.74
- MACD
- CMS -0.03
- BNTX -0.80
- Stochastic Oscillator
- CMS 52.33
- BNTX 29.03
About CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. CMS Enterprises is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.